LaunchQ4 2026
Founding capacity$10–20M
Target net yield10%

Pipeline

A sample of the deals in Dealport's pipeline today: the senior secured credit EagleUSD is built to hold.

A sample, not the portfolio

A few of the deals in the pipeline at Dealport, our sister M&A platform. No loans have been funded and EagleUSD is not yet live.

Project NurseryProprietary

Pediatric NICU devices, three-company roll-up

Senior secured financing for a sponsor-backed combination of three specialty medical-device and consumer-health businesses, led by an established NICU catheter line.

Senior loan
$30–35MSenior secured
Coupon
~12%Floating, SOFR-based
Loan-to-value
30–35%All-in
Equity below the loan
$60M+About two-thirds of value

Why it fits. About two-thirds of enterprise value sits below the loan, on products already in market with recurring demand.

Project ReindeerUnder exclusivity

Urology lasers and single-use consumables

A founder-owned company that places surgical lasers at hospitals and surgery centers and sells the single-use products each procedure needs. A sponsor is recapitalizing it under exclusivity.

Revenue
$5–10M2025, growing 20%+
EBITDA
$3–5MAbout 40% margin
Recurring revenue
~90%Consumables and rentals
Enterprise value
$25–30MAbout 6× forward EBITDA

Why it fits. Demand follows procedure volume through a fleet of placed lasers, and no customer is more than 20% of revenue.

Project Golden StateLOI signed

Multi-site California outpatient imaging

An MRI, CT and mammography group with more than 20 years of profitable operation, being acquired by a public-company buyer under a signed letter of intent.

Revenue
$10–15MFY2025, unaudited
EBITDA
$4–5MAbout 45–50% margin
Track record
20+ yearsProfitable every year
Payor mix
≤25%No single payor above

Why it fits. New imaging equipment at close keeps near-term capital spending low, and the clinical team stays on after the sale.

Figures are company-reported and have not been through diligence. Deals are codenamed for confidentiality. Read the underwriting standard →